Alzheimer's drug could slow disease by 8 years
New real-world data suggests lecanemab's impact is greater than thought, prompting calls for NHS trial access. Over 130 Alzheimer's drugs are in clinical trials.
Category : Search result: lecanemab
NHS approves groundbreaking dementia drugs in major U-turn
In a major policy shift, NICE recommends three new dementia drugs for widespread NHS use, offering hope to thousands with early-stage Alzheimer's.
Page 1 of 1